Antineoplastic adverse reaction (disorder)
| Code | 292196008 |
|---|---|
| Semantic tag | disorder |
| Module | international |
| Definition | defined |
| Effective time | 20060131 |
62014003Adverse reaction to drug
disorder
218326006Adverse reaction to antineoplastic antibiotics
disorder
442108004Adverse reaction to rituximab administered by infusion
disorder
441858005Adverse reaction to trastuzumab administered by infusion
disorder
292190002Aldesleukin adverse reaction
disorder
292197004Alkylating drug adverse reaction
disorder
292245004Aminoglutethimide adverse reaction
disorder
292236000Amsacrine adverse reaction
disorder
292227004Antimetabolite adverse reaction
disorder
293230000Bicalutamide adverse reaction
disorder
292237009Carboplatin adverse reaction
disorder
292238004Cisplatin adverse reaction
disorder
292242001Crisantaspase adverse reaction
disorder
293232008Cyproterone adverse reaction
disorder
293081004Dapsone adverse reaction
disorder
402752000Dermatosis due to cytotoxic therapy
disorder
293166008Dexamethasone adverse reaction
disorder
292254001Dimethyl sulphoxide adverse reaction
disorder
292235001Etoposide adverse reaction
disorder
293229005Flutamide adverse reaction
disorder
292249005Formestane adverse reaction
disorder
292239007Hydroxycarbamide adverse reaction
disorder
292835006Interferons adverse reaction
disorder
293283008Leuprorelin adverse reaction
disorder
293213002Megestrol adverse reaction
disorder
292243006Paclitaxel adverse reaction
disorder
293170000Prednisolone adverse reaction
disorder
293146004Prednisone adverse reaction
disorder
292240009Procarbazine adverse reaction
disorder
292241008Razoxane adverse reaction
disorder
292247007Trilostane adverse reaction
disorder
293281005Triptorelin adverse reaction
disorder
292250005Vinca alkaloid adverse reaction
disorder